Showing results (1-10 of 117) with videos related to
Sort By:
Pageof 12
Cancers|June 2, 2021
Therapeutics Targeting the Core Apoptotic MachineryClaudia Hamilton, Jennifer P Fox, Daniel B Longley, et al.Cancers|March 25, 2022
Correction: Hamilton et al. Therapeutics Targeting the Core Apoptotic Machinery. Cancers 2021, 13, 2618Claudia Hamilton, Jennifer P Fox, Daniel B Longley, et al.Cell Reports|November 21, 2023
cFLIPL acts as a suppressor of TRAIL- and Fas-initiated inflammation by inhibiting assembly of caspase-8/FADD/RIPK1 NF-κB-activating complexesPavel Davidovich, Catherine A Higgins, Zaneta Najda, et al.EMBO Reports|February 4, 2020
A revised model of TRAIL-R2 DISC assembly explains how FLIP(L) can inhibit or promote apoptosisLuke M Humphreys, Jennifer P Fox, Catherine A Higgins, et al.The FEBS Journal|May 29, 2018
FLIP as a therapeutic target in cancerLuke Humphreys, Margarita Espona-Fiedler, Daniel B LongleyCell Death and Differentiation|December 16, 2021
The role of Ubiquitination in Apoptosis and NecroptosisJamie Z Roberts, Nyree Crawford, Daniel B LongleyClinical Colorectal Cancer|March 7, 2003
Predictive markers for colorectal cancer: current status and future prospectsDaniel B Longley, Ultan McDermott, Patrick G JohnstonCell Death Discovery|July 28, 2020
Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancerJennifer Ferris, Margarita Espona-Fiedler, Claudia Hamilton, et al.Nature Reviews. Cancer|May 2, 2003
5-fluorouracil: mechanisms of action and clinical strategiesDaniel B Longley, D Paul Harkin, Patrick G JohnstonPageof 12